FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1482681188> ?p ?o ?g. }

• W1482681188 endingPage "446" @default.
• W1482681188 startingPage "440" @default.
• W1482681188 abstract "What’s known on the subject? and What does the study add? Vasoactive intestinal polypeptide (VIP) is an important erectile neurotransmitter, and our previous study found that the mRNA expression of VIP was independent of androgens. The present study further investigated the vivo effect of VIP on erection. We found that not only the expression of VIP was independent of androgens, but also the effect of VIP on erection was independent of androgens. In fact, we found that VIP played a more significant role on erection in castrated rats than in normal rats. OBJECTIVE To investigate the regulatory role of androgen in VIP‐mediated erectile effect. Androgen is essential for physiological erection. Vasoactive intestinal polypeptide (VIP) is an important erectile neurotransmitter. While previous studies demonstrated that VIP expression in the penis was androgen‐independent, it remains controversial whether androgen has any effect on VIP‐mediated erection. MATERIALS AND METHODS Male SD rats were divided into a control group, a castration group, and a castration‐with‐testosterone‐replacement group. Four weeks later, each group was subdivided into low and high‐dose VIP subgroups and subjected to intracavernous injection of 0.5 and 2 µg VIP, respectively. Erectile function was tested by recording intracavernosal pressure (ICP) and mean arterial blood pressure (MAP) before and after VIP injection. The expressions of the VIP‐receptor (VPAC2), G‐protein stimulatory and inhibitory alpha subunits (Gs‐α, Gi‐α), and PDE3A in rat corpus cavernosum (CC) was qualified by real‐time PCR and Western blot analysis. RESULTS Castration reduced erectile function while testosterone restored it. VIP improved erectile function in a dose‐dependent manner. High‐dose VIP significantly enhanced erectile function in castrated rats and there was no difference of ICP/MAP among three groups after injection of high‐dose VIP. Low‐dose VIP also resulted in a higher improvement of erectile function in castrated rats, although the ICP/MAP was lower in these rats than in the other two groups. VPAC2 and Gs‐α were up‐regulated while Gi‐α and PDE3A were down‐regulated in CC of castrated rats. CONCLUSION VIP improves erectile function much more significantly in hypogonadal condition, mainly due to the higher expression of VPAC2, Gs‐α, and lower expression of Gi‐α and PDE3A in CC of castrated rats. Androgen may negatively regulate the erectile effect of VIP." @default.
• W1482681188 created "2016-06-24" @default.
• W1482681188 creator A5020911361 @default.
• W1482681188 creator A5022585660 @default.
• W1482681188 creator A5024120299 @default.
• W1482681188 creator A5039877012 @default.
• W1482681188 creator A5052753139 @default.
• W1482681188 creator A5065023138 @default.
• W1482681188 creator A5085014810 @default.
• W1482681188 date "2010-12-16" @default.
• W1482681188 modified "2023-10-17" @default.
• W1482681188 title "Vasoactive intestinal polypeptide, an erectile neurotransmitter, improves erectile function more significantly in castrated rats than in normal rats" @default.
• W1482681188 cites W1586694314 @default.
• W1482681188 cites W1947913727 @default.
• W1482681188 cites W1964764123 @default.
• W1482681188 cites W1986110768 @default.
• W1482681188 cites W1994087358 @default.
• W1482681188 cites W1997466448 @default.
• W1482681188 cites W1997825003 @default.
• W1482681188 cites W1999181000 @default.
• W1482681188 cites W2001741671 @default.
• W1482681188 cites W2009131432 @default.
• W1482681188 cites W2015050915 @default.
• W1482681188 cites W2021376335 @default.
• W1482681188 cites W2022246890 @default.
• W1482681188 cites W2032350393 @default.
• W1482681188 cites W2036005153 @default.
• W1482681188 cites W2038781337 @default.
• W1482681188 cites W2040126239 @default.
• W1482681188 cites W2056183365 @default.
• W1482681188 cites W2070814929 @default.
• W1482681188 cites W2074489144 @default.
• W1482681188 cites W2078091238 @default.
• W1482681188 cites W2086936041 @default.
• W1482681188 cites W2091026717 @default.
• W1482681188 cites W2091839764 @default.
• W1482681188 cites W2108148925 @default.
• W1482681188 cites W2109596022 @default.
• W1482681188 cites W2118800368 @default.
• W1482681188 cites W2142623609 @default.
• W1482681188 cites W2146841174 @default.
• W1482681188 doi "https://doi.org/10.1111/j.1464-410x.2010.09901.x" @default.
• W1482681188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21166748" @default.
• W1482681188 hasPublicationYear "2010" @default.
• W1482681188 type Work @default.
• W1482681188 sameAs 1482681188 @default.
• W1482681188 citedByCount "14" @default.
• W1482681188 countsByYear W14826811882012 @default.
• W1482681188 countsByYear W14826811882013 @default.
• W1482681188 countsByYear W14826811882015 @default.
• W1482681188 countsByYear W14826811882016 @default.
• W1482681188 countsByYear W14826811882018 @default.
• W1482681188 countsByYear W14826811882019 @default.
• W1482681188 countsByYear W14826811882021 @default.
• W1482681188 countsByYear W14826811882023 @default.
• W1482681188 crossrefType "journal-article" @default.
• W1482681188 hasAuthorship W1482681188A5020911361 @default.
• W1482681188 hasAuthorship W1482681188A5022585660 @default.
• W1482681188 hasAuthorship W1482681188A5024120299 @default.
• W1482681188 hasAuthorship W1482681188A5039877012 @default.
• W1482681188 hasAuthorship W1482681188A5052753139 @default.
• W1482681188 hasAuthorship W1482681188A5065023138 @default.
• W1482681188 hasAuthorship W1482681188A5085014810 @default.
• W1482681188 hasConcept C105702510 @default.
• W1482681188 hasConcept C118303440 @default.
• W1482681188 hasConcept C126322002 @default.
• W1482681188 hasConcept C134018914 @default.
• W1482681188 hasConcept C170493617 @default.
• W1482681188 hasConcept C2776219046 @default.
• W1482681188 hasConcept C2777786686 @default.
• W1482681188 hasConcept C2777911890 @default.
• W1482681188 hasConcept C2778509035 @default.
• W1482681188 hasConcept C2779256933 @default.
• W1482681188 hasConcept C2779279991 @default.
• W1482681188 hasConcept C2779929075 @default.
• W1482681188 hasConcept C71315377 @default.
• W1482681188 hasConcept C71924100 @default.
• W1482681188 hasConcept C8330315 @default.
• W1482681188 hasConceptScore W1482681188C105702510 @default.
• W1482681188 hasConceptScore W1482681188C118303440 @default.
• W1482681188 hasConceptScore W1482681188C126322002 @default.
• W1482681188 hasConceptScore W1482681188C134018914 @default.
• W1482681188 hasConceptScore W1482681188C170493617 @default.
• W1482681188 hasConceptScore W1482681188C2776219046 @default.
• W1482681188 hasConceptScore W1482681188C2777786686 @default.
• W1482681188 hasConceptScore W1482681188C2777911890 @default.
• W1482681188 hasConceptScore W1482681188C2778509035 @default.
• W1482681188 hasConceptScore W1482681188C2779256933 @default.
• W1482681188 hasConceptScore W1482681188C2779279991 @default.
• W1482681188 hasConceptScore W1482681188C2779929075 @default.
• W1482681188 hasConceptScore W1482681188C71315377 @default.
• W1482681188 hasConceptScore W1482681188C71924100 @default.
• W1482681188 hasConceptScore W1482681188C8330315 @default.
• W1482681188 hasIssue "3" @default.
• W1482681188 hasLocation W14826811881 @default.
• W1482681188 hasLocation W14826811882 @default.
• W1482681188 hasOpenAccess W1482681188 @default.
• W1482681188 hasPrimaryLocation W14826811881 @default.

• next